A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1992
11/10/1992	CA1310010C Benzimidazole derivatives, their preparation and their application in therapeutics
11/10/1992	CA1309951C Press coated dhp tablets
11/10/1992	CA1309950C Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
11/10/1992	CA1309949C Contraceptive implant
11/09/1992	WO1992019211A2 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
11/09/1992	CA2106968A1 Imidazobenzoquinones and compositions for preventing or treating hypertension or congestive heart failure containing the same
11/09/1992	CA2042138A1 Agents for preventing or treating bacterial diseases of fishes
11/08/1992	WO1992019241A1 A controlled, sustained release delivery system for smoking cessation
11/08/1992	CA2102507A1 A controlled, sustained release delivery system for smoking cessation
11/08/1992	CA2068054A1 Fibrinogen receptor antagonists
11/08/1992	CA2063895A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan
11/08/1992	CA2063752A1 Angiotensin ii antagonists incorporating a substituted benzyl element
11/07/1992	WO1992019251A1 Combined calcium and vitamin d supplements
11/05/1992	WO1992019628A1 Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
11/05/1992	DE4114586A1 Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung Medicines containing azacyclodiphosphonsaeurederivate new azacyclodiphosphonsaeurederivate and procedures for their production
11/05/1992	DE4114330A1 Neue arzneimittelkombination New drug combination
11/05/1992	DE4113984A1 Salze der 4-hydroxy-buttersaeure Salts of 4-hydroxy-butyric acid
11/05/1992	CA2109318A1 Medicaments containing azacyclodiphosphonic acid derivatives, new azacyclodiphosphonic acid derivatives, as well as processes for their preparation
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	WO1992019605A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992	WO1992019247A1 Erythromycin derivatives
11/04/1992	WO1992019232A1 Partial liquid breathing of fluorocarbons
11/04/1992	EP0511943A2 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same
11/04/1992	EP0511940A2 Phosphono/biaryl substituted dipeptide derivatives
11/04/1992	EP0511932A2 Process for the obtaining of polymers with activity on the hematopoietic system
11/04/1992	EP0511917A1 Glycosylated prodrugs, process for their preparation and uses thereof
11/04/1992	EP0511881A1 Novel anthelmintic milbemycin analogs of novel microorganisms
11/04/1992	EP0511879A1 Pyrazine derivatives
11/04/1992	EP0511867A1 Process for the preparation of simvastatin
11/04/1992	EP0511865A1 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
11/04/1992	EP0511800A1 Pharmaceutical formulation containing dirithromycin
11/04/1992	EP0511799A1 Pharmaceutical compounds
11/04/1992	EP0511792A2 Pyridoprimidine derivatives as antineoplastic agents
11/04/1992	EP0511791A2 Pyrrolopyridine derivatives as Angiotensin inhibitors
11/04/1992	EP0511767A1 Tablets containing compound DUP753
11/04/1992	EP0511727A1 14-alpha,17alpha-(propano- and 17,2-propeno)-estratrienes
11/04/1992	EP0511703A2 Pharmaceutical composition, containing sucralfate and carrageenan, useful for gastroenterology
11/04/1992	EP0511610A1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments
11/04/1992	EP0511587A1 Slimming composition
11/04/1992	EP0511563A1 Process for the preparation of 4'-demethylepipodophyllotoxin glucoside 4'-phosphates
11/04/1992	EP0511347A1 Meta-substituted phenyl alanine derivatives
11/04/1992	EP0511325A1 A rapid method for interrupting or attenuating poly-drug dependency syndromes
11/04/1992	EP0511297A1 Oxathiane derivatives
11/04/1992	EP0511275A1 Chelating compounds
11/04/1992	EP0511271A1 Thiazole derivatives
11/04/1992	EP0511270A1 New thiazole derivatives
11/04/1992	EP0511228A1 Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors
11/04/1992	EP0498843A4 Oligonucleotide analogs with novel linkages
11/04/1992	EP0437554B1 Pharmaceutical composition and method of inhibiting virus
11/04/1992	EP0191814B1 Protein absorption enhancing agents
11/04/1992	CN1065866A Prodrug esters of phenolic 2-piperidino-1-alkanols
11/04/1992	CN1065865A Indole and dihydroquinoline potassium channel openers
11/04/1992	CN1065863A Pyrimidine derivatives for enhancing antitumor activity
11/04/1992	CN1018924B Process for preparing copolymers of vinyl alcohol with embedded glutaric aldehyde and vinyl acetic-ester
11/04/1992	CN1018923B Process for preparing pyridine deriv. having anti-ulcerative activity
11/04/1992	CA2108902A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992	CA2107793A1 Erythromycin derivatives
11/04/1992	CA2086510A1 Rna delivry vector
11/04/1992	CA2067905A1 Benzopyranic compounds, process for the preparation thereof, and pharmaceutical compositions containing them
11/04/1992	CA2067839A1 Use of estrogens or antiandrogens or estrogens in combination with antiandrogens for reversal of male sexual phenotype in poultry
11/04/1992	CA2067834A1 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
11/04/1992	CA2041828A1 Viscoelastic solution
11/03/1992	WO1992019594A1 Pyrrolidinones
11/03/1992	WO1992019246A1 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
11/03/1992	US5160744 Verapmil therapy
11/03/1992	US5160737 Acrylic copolymer; sustained release; dentistry, dermatology
11/03/1992	US5160734 Complex with polyoxyethylene-polyoxypropylene copolymer
11/03/1992	US5160728 Sodium carbonate, neutralization, potassium carbonate
11/03/1992	US5160727 Tumor cell sensitization method using quinazolinedione derivatives
11/03/1992	US5160469 Manufacture of pellets of xanthine derivatives
11/03/1992	CA2102120A1 Use of a 1,3-oxathlolan derivative for the treatment of hepatitis b infection
11/03/1992	CA2102106A1 Pyrrolidinones
11/03/1992	CA2067648A1 Octahydrobenzo[g]quinoline
11/03/1992	CA2067520A1 Treatment of mastitis
11/03/1992	CA1309719C Heterocycly1-2-propyn-1-amines
11/03/1992	CA1309718C 5-(6-imidazo[1,2-a]pyridyl)pyridine derivative
11/03/1992	CA1309717C Promoting agents of the activity of some antitumor agents against various kinds of tumor cells including multiple drug resistant tumor cells andtheir synthetic methods
11/03/1992	CA1309714C Process for the preparation of (2s,3s)-3-acetoxy-5-(n, n-dimethylaminoethyl)-2-(4-methoxyphenyl)-2,3-dihydro- 1,5-benzothiazepin-4(5h)-one
11/03/1992	CA1309663C Method and composition for treatment and prevention of pseudofolliculitis barbae
11/03/1992	CA1309662C GASTROPROTECTIVE COMPOSITION CONTAINING .beta.-ADRENERGIC AGONISTS
11/03/1992	CA1309661C Transdermal delivery system
11/03/1992	CA1309660C Anxiolytic-n-(1-azabicyclo¬2.2.2\|oct-3-yl) benzamides and thiobenzamides
11/03/1992	CA1309659C Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
11/03/1992	CA1309658C Pharmaceutical compositions for treatment of hyperproliferate skin disease
11/03/1992	CA1309656C Sustained-release drug preparation
11/02/1992	WO1992019250A1 Method for treating hypothermia
11/02/1992	CA2109418A1 Glycine anhydride dimethylol as a biocide and preservative
11/02/1992	CA2102094A1 Method for treating hypothermia
11/02/1992	CA2067723A1 Antheilmintic milbemycin analogs of novel microorganisms
11/02/1992	CA2067722A1 Process for simvastatin
11/02/1992	CA2067663A1 Pyrazine derivatives
11/02/1992	CA2067592A1 Phosphono/biaryl substituted dipeptide derviatives
11/02/1992	CA2067298A1 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
10/1992
10/31/1992	WO1992019642A1 14α,17α-(PROPANO AND 172-PROPENO)ESTRATRIENES
10/31/1992	WO1992019641A1 14α,16α-ETHANO AND 14α,16α-ETHENO ESTRATRIENES
10/31/1992	WO1992019632A1 Trifluoromethyl analogs of fucose and uses thereof
10/31/1992	CA2107787A1 14.alpha., 17.alpha.-(propano and 17²-propeno)estratrienes
10/31/1992	CA2107361A1 14.alpha.,16.alpha.-ethano and 14.alpha.,16.alpha.-ethano estratrienes
10/31/1992	CA2106785A1 Trifluoromethyl analogs of fucose and uses thereof
10/31/1992	CA2066005A1 Nitrogen derivatives

1 ... 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 7253 7254 7255 7256 ... 7860